Martini Silvia, Bonechi Claudia, Corbini Gianfranco, Donati Alessandro, Rossi Claudio
Department of Chemical and Biosystem Sciences, University of Siena, Via Aldo Moro, 2-53100 Siena, Italy.
Bioorg Med Chem. 2004 May 1;12(9):2163-72. doi: 10.1016/j.bmc.2004.02.027.
The solution structure of rifaximin and its derivative rifaximin OR (open ring) was determined by combining NMR experimental results, theoretical simulation of two-dimensional NMR spectra by complete relaxation matrix analysis (corma), and molecular dynamics calculations. In this study the structural rearrangements due to the opening of the aliphatic chain of rifaximin after the reduction process to form rifaximin OR were investigated. Close spatial proximity of CH(3)(14) and H28b protons detected by 2D-ROESY spectrum of rifaximin OR, which was not present in rifaximin and the down-field shift of CH(3)(34) protons in rifaximin OR (1)H spectrum were crucial to understand the structural modifications, which occurred within the system. The aliphatic chain of rifaximin OR was found to be no longer symmetrical with respect to the aromatic moiety. Although no dramatic structural rearrangements were detected, the aliphatic chain moved toward CH(3)(14), causing a reduction of the aromatic shielding contribution in particular on CH(3)(34).
通过结合核磁共振实验结果、利用完全弛豫矩阵分析(corma)对二维核磁共振谱进行理论模拟以及分子动力学计算,确定了利福昔明及其衍生物利福昔明OR(开环)的溶液结构。在本研究中,对利福昔明在还原过程中形成利福昔明OR后脂肪链开环所导致的结构重排进行了研究。利福昔明OR的二维ROESY谱检测到CH(3)(14)和H28b质子紧密的空间接近性,这在利福昔明中不存在,以及利福昔明OR的(1)H谱中CH(3)(34)质子的低场位移,对于理解系统内发生的结构修饰至关重要。发现利福昔明OR的脂肪链相对于芳香部分不再对称。尽管未检测到显著的结构重排,但脂肪链向CH(3)(14)移动,导致特别是对CH(3)(34)的芳香屏蔽贡献减少。